In Malignant melanoma Malignant melanoma is a type of skin cancer that develops in melanocytes, the cells that produce the pigment called melanin. Melanin is the pigment that gives the skin its color. Malignant melanoma is the most deadly and aggressive kind of skin cancer. Oncodac 200mg Injection sticks to the genetic code, called DNA,of the cancer cells and kills them . It also prevents their growth and further spread. This helps to treat the cancer. In Hodgkin’s disease Hodgkin’s disease is a type of lymphoma, which is a blood cancer that starts in the lymphatic system. The lymphatic system helps the immune system get rid of waste and fight infections. Oncodac 200mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Follow your doctor’s instructions carefully.
Caution is advised when consuming alcohol with Oncodac 200mg Injection. Please consult your doctor.
Oncodac 200mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Oncodac 200mg Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Oncodac 200mg Injection may cause side effects which could affect your ability to drive. Oncodac 200mg Injection may influence the ability to drive because of its central nervous system side effects.
Oncodac 200mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Oncodac 200mg Injection may be needed. Please consult your doctor.
Oncodac 200mg Injection should be used with caution in patients with liver disease. Dose adjustment of Oncodac 200mg Injection may be needed. Please consult your doctor.
If you miss a dose of Oncodac 200mg Injection, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Criticare Laboratories Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Alkem Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Alkem Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Getwell Oncology Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: United Biotech Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cipla Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zuvius Life Sciences || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Neon Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Miracalus Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Taj Pharma India Ltd || ₹14.5/tablet (25% cheaper)